Gene · 6595
Papers3,459
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,459
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37217462 | PubTator, text mining | PubMed |
| Case Report: Nintedanib for immune-related pneumonitis triggered by anti-PD-1 treatment in a patient with SMARCA4-mutant NSCLC: a case report. | Front Pharmacol | 2023 | 37214462 | PubTator, text mining | PubMed |
| Temporal transcriptional control of neural induction in human induced pluripotent stem cells. | Front Mol Neurosci | 2023 | 37213689 | PubTator, text mining | PubMed |
| Alanine supplementation exploits glutamine dependency induced by SMARCA4/2-loss. | Nat Commun | 2023 | 37210563 | PubTator, text mining | PubMed |
| Targeting PHB1 to inhibit castration-resistant prostate cancer progression in vitro and in vivo. | J Exp Clin Cancer Res | 2023 | 37210546 | PubTator, text mining | PubMed |
| SMARCB1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature. | Am J Case Rep | 2023 | 37198880 | PubTator, text mining | PubMed |
| Multiomics analysis of adaptation to repeated DNA damage in prostate cancer cells. | Epigenetics | 2023 | 37196186 | PubTator, text mining | PubMed |
| Arabidopsis thaliana: a powerful model organism to explore histone modifications and their upstream regulations. | Epigenetics | 2023 | 37196184 | PubTator, text mining | PubMed |
| The NuRD Complex in Neurodevelopment and Disease: A Case of Sliding Doors. | Cells | 2023 | 37190088 | PubTator, text mining | PubMed |
| Identification of Extremely Rare Pathogenic CNVs by Array CGH in Saudi Children with Developmental Delay, Congenital Malformations, and Intellectual Disability. | Children (Basel) | 2023 | 37189911 | PubTator, text mining | PubMed |
| Clinical activity of pembrolizumab with or without chemotherapy in advanced pulmonary large-cell and large-cell neuroendocrine carcinomas: a multicenter retrospective cohort study. | BMC Cancer | 2023 | 37189075 | PubTator, text mining | PubMed |
| Identification and validation of biomarkers based on cellular senescence in mild cognitive impairment. | Front Aging Neurosci | 2023 | 37187578 | PubTator, text mining | PubMed |
| Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity. | Clin Transl Med | 2023 | 37186134 | PubTator, text mining | PubMed |
| Histological markers, sickle-shaped blood vessels, myxoid area, and infiltrating growth pattern help stratify the prognosis of patients with myxofibrosarcoma/undifferentiated sarcoma. | Sci Rep | 2023 | 37185612 | PubTator, text mining | PubMed |
| Clinical characteristics and prognostic analysis of SMARCA4-deficient non-small cell lung cancer. | Cancer Med | 2023 | 37184108 | PubTator, text mining | PubMed |
| Role of brahma-related gene 1/brahma-associated factor subunits in neural stem/progenitor cells and related neural developmental disorders. | World J Stem Cells | 2023 | 37181007 | PubTator, text mining | PubMed |
| Effectiveness of tislelizumab when combined with etoposide and carboplatin in patients with SMARCA4-deficient undifferentiated thoracic tumor: a case report. | Transl Cancer Res | 2023 | 37180644 | PubTator, text mining | PubMed |
| Molecular Mechanisms Underlying Pluripotency and Self-Renewal of Embryonic Stem Cells. | Int J Mol Sci | 2023 | 37176093 | PubTator, text mining | PubMed |
| Mutual Regulation of ncRNAs and Chromatin Remodeling Complexes in Normal and Pathological Conditions. | Int J Mol Sci | 2023 | 37175555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6595/papers?page=21